Qualitative and Quantitative Heterogeniety in Acquiring Resistance to EGFR Kinase Inhibitors in Lung Cancer

被引：0
作者：
Suda, Kenichi [1 ]
Murakami, Isao [2 ]
Sakai, Kazuko [3 ]
Mizuuchi, Hiroshi [1 ]
Sato, Katsuaki [1 ]
Tomizawa, Kenji [1 ]
Nishio, Kazuto [3 ]
Mitsudomi, Tetsuya [1 ]
机构：
[1] Kinki Univ, Fac Med, Dept Surg, Div Thorac Surg, Osaka, Japan
[2] Higashi Hiroshima Med Ctr, Dept Resp Med, Higashihiroshima, Japan
[3] Kinki Univ, Fac Med, Dept Genome Biol, Osaka, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
T790M mutation; Molecular targeted therapy; EGFR mutation; lung adenocarcinoma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ORAL42.02
引用
收藏
页码：S256 / S257
页数：2
相关论文
共 50 条
  • [11] Outcomes in Patients With Lung Adenocarcinoma With Transformation to Small Cell Lung Cancer After EGFR Tyrosine Kinase Inhibitors Resistance: A Systematic Review and Pooled Analysis
    Xu, Jinhe
    Xu, Lihuan
    Wang, Baoshan
    Kong, Wencui
    Chen, Ying
    Yu, Zongyang
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [12] Challenges in the Management of EGFR-Mutated Non-Small Cell Lung Cancer Patients with Acquired Resistance to Tyrosine Kinase Inhibitors
    Kuiper, Justine L.
    Smit, Egbert F.
    ONCOLOGY, 2014, 87 (02) : 83 - 94
  • [13] Tyrosine Kinase Inhibitors in Lung Cancer
    Thomas, Anish
    Rajan, Arun
    Giaccone, Giuseppe
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2012, 26 (03) : 589 - +
  • [14] Heterogeneity in Immune Marker Expression after Acquisition of Resistance to EGFR Kinase Inhibitors: Analysis of a Case with Small Cell Lung Cancer Transformation
    Suda, Kenichi
    Murakami, Isao
    Yu, Hui
    Kim, Jihye
    Ellison, Kim
    Rivard, Christopher J.
    Mitsudomi, Tetsuya
    Hirsch, Fred R.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (06) : 1015 - 1020
  • [15] Spatial heterogeneity of acquired resistance mechanisms to 1st/2nd generation EGFR tyrosine kinase inhibitors in lung cancer
    Suda, Kenichi
    Murakami, Isao
    Obata, Keiko
    Sakai, Kazuko
    Fujino, Toshio
    Koga, Takamasa
    Ohara, Shuta
    Hamada, Akira
    Soh, Junichi
    Nishio, Kazuto
    Mitsudomi, Tetsuya
    LUNG CANCER, 2020, 148 : 100 - 104
  • [16] Lack of response to EGFR tyrosine kinase inhibitors in an amylase-producing lung cancer with a preexisting MET amplification
    Nemoto, Kenji
    Hayashihara, Kenji
    Oh-ishi, Shuji
    Nakazawa, Mariko
    Fujita, Kazutaka
    Sakurai, Hirofumi
    Kanazawa, Jun
    Shih-Yuan, Lin
    Takaku, Takio
    Minami, Yuko
    Saito, Takefumi
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2015, 4 (04): : 236 - 240
  • [17] Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations
    Kim, Min Hwan
    Kim, Hye Ryun
    Cho, Byoung Chul
    Bae, Mi Kyung
    Kim, Eun Young
    Lee, Chang Young
    Lee, Jae Seok
    Kang, Dae Ryong
    Kim, Joo Hang
    LUNG CANCER, 2014, 84 (02) : 196 - 202
  • [18] HDAC Inhibitors Overcome New Generation EGFR-TKI-Resistance Caused by Homozygous BIM Polymorphism in EGFR Mutant Lung Cancer
    Yano, Seiji
    Tanimoto, Azusa
    Arai, Shoko
    Fukuda, Koji
    Ong, Sin T.
    Takeuchi, Shinji
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S296 - S297
  • [19] Lack of response to EGFR tyrosine kinase inhibitors in an amylase-producing lung cancer with a preexisting MET amplification
    Kenji Nemoto
    Kenji Hayashihara
    Shuji Oh-ishi
    Mariko Nakazawa
    Kazutaka Fujita
    Hirofumi Sakurai
    Jun Kanazawa
    Lin Shih-Yuan
    Takio Takaku
    Yuko Minami
    Takefumi Saito
    International Cancer Conference Journal, 2015, 4 (4) : 236 - 240
  • [20] Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation
    Bruno, Rossella
    Del Re, Marzia
    Cucchiara, Federico
    Petrini, Iacopo
    Ali, Greta
    Crucitta, Stefania
    Proietti, Agnese
    Valleggi, Simona
    Chella, Antonio
    Danesi, Romano
    Fontanini, Gabriella
    FRONTIERS IN ONCOLOGY, 2021, 11
12345